Your browser doesn't support javascript.
loading
ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma.
Niyazi, Maximilian; Andratschke, Nicolaus; Bendszus, Martin; Chalmers, Anthony J; Erridge, Sara C; Galldiks, Norbert; Lagerwaard, Frank J; Navarria, Pierina; Munck Af Rosenschöld, Per; Ricardi, Umberto; van den Bent, Martin J; Weller, Michael; Belka, Claus; Minniti, Giuseppe.
Afiliação
  • Niyazi M; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany; Bavarian Cancer Research Center (BZKF), Munich, Germany. Electronic address: Maximilian.Niyazi@med.uni-muenchen.de.
  • Andratschke N; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Bendszus M; Department of Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany.
  • Chalmers AJ; School of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK.
  • Erridge SC; Edinburgh Centre for Neuro-Oncology, University of Edinburgh, Western General Hospital, Edinburgh EH4 1EU, UK.
  • Galldiks N; Department of Neurology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany; Institute of Neuroscience and Medicine (INM-3), Research Center Juelich, Juelich, Germany; Center for Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf,
  • Lagerwaard FJ; Department of Radiation Oncology, Amsterdam UMC location Vrije Universiteit Amsterdam, the Netherlands.
  • Navarria P; Radiotherapy and Radiosurgery Department, IRCCS, Humanitas Research Hospital, Rozzano, MI, Italy.
  • Munck Af Rosenschöld P; Radiation Physics, Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, and Lund University, Lund, Sweden.
  • Ricardi U; Department of Oncology, University of Turin, Turin, Italy.
  • van den Bent MJ; Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Weller M; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
  • Belka C; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany; Bavarian Cancer Research Center (BZKF), Munich, Germany.
  • Minniti G; Dept. of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy; IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli, Italy.
Radiother Oncol ; 184: 109663, 2023 07.
Article em En | MEDLINE | ID: mdl-37059335

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioblastoma Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Humans Idioma: En Revista: Radiother Oncol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioblastoma Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Humans Idioma: En Revista: Radiother Oncol Ano de publicação: 2023 Tipo de documento: Article